Active Ingredient(s): Ivacaftor + Tezacaftor
FDA Approved: * February 12, 2018
Pharm Company: * VERTEX PHARMS INC
Category: Genetic Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Symdeko Overview

Tezacaftor, also known as VX-661, is a drug approved by the FDA to treat some cases of cystic fibrosis. In 2018, the FDA approved a combination of ivacaftor and tezacaftor; the manufacturer announced a list price of $292,000 per year.[1] The combination of ivacaftor and tezacaftor is being sold as Symdeko.[2] Contents 1 Mechanism of action 2 Properties 3 Clinical trials 4 References Mechanism of action Tezacaftor helps move the CFTR protein to the corr...

Read more Symdeko Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Symdeko Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ivacaftor + Tezacaftor
  • Tablet, Tablet: 150mg,n/a + 150mg, 100mg, 75mg,n/a + 75mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Symdeko: (2 results)

Sorted by National Drug Code
  • 51167-113 SymdekoSymdeko Kit by Vertex Pharmaceuticals Incorporated
  • 51167-661 Symdeko Kit by Vertex Pharmaceuticals Incorporated

Drugs with one or more similar ingredients: (5 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA